Search results
View tables reflecting the number of bone marrow and cord blood transplants performed at transplant centers in the US, by patient age, patient gender, patient race, cell source, the year when the transplant was performed, disease, donor type, and the state in which the transplant center is located.
- Previous Methodology
The CIBMTR performs a center-specific survival analysis each...
- Center-Specific Survival Analysis
Outcomes reporting in allogeneic HCT is necessary to provide...
- Related Websites
Our websites: Medical College of Wisconsin; NMDP (website...
- Research Tools & Calculators
DataOps Dashboard: Download data regarding COVID impacts,...
- Publications
CIBMTR Publication List. Since 1972, using CIBMTR data and...
- Publicly Available Datasets
The CIBMTR makes its publication analysis datasets freely...
- Previous Methodology
The mean change in height z‐score at 12 months is 0.12 from transplant. Growth patterns post‐transplant vary by age with the youngest patients experi‐encing the most z‐score improvement (age 0‐1: 0.54, age 2‐5: 0.38, age 6‐12: 0.07, age ≥13: 0.03) in their mean height deficit (Figure 5, panel B).
17 lip 2020 · 3 RESULTS. We included 331,216 kidney transplant recipients in the study, of which 210,665 (63.6%) were recipients of deceased donor kidneys, and 120,551 (36.4%) of living donors. Table 1 shows the recipient characteristics across the different eras.
29 gru 2023 · We also examined time to death and all-cause graft loss (ACGL) (the composite of death or graft loss) at 6 months, 1 year, and 5 years post-transplant in patients with follow-up in Nova Scotia (“NS only cohort”; Figure 1).
This website shows 5-tier outcome assessments for three metrics: survival on the waiting list (pre-transplant mortality rate), getting a transplant faster (transplant rate), and 1-year organ survival (first-year graft survival).
5 maj 2021 · Fig. 1: Key areas in which specific measures should be considered to promote transplantation.
We performed a multicenter, retrospective, observational study in 3 transplant centers in Poland (Gdańsk, Bydgoszcz, and Bialystok). Patients that underwent kidney transplantation procedures performed between January 1994 and December 2016 were checked for eligibility for the study.
